Magnera Corp placeholder (MAGN) AI Stock Analysis

Magnera Corporation manufactures and sells non-woven and related products worldwide, focusing on consumer-oriented end markets like healthcare and personal care. Its product catalog features personal care and consumer solution components including medical garments, wipes, dryer sheets, filtration media, baby diapers, and adult incontinence solutions. The company also produces tea bags, coffee filters, cable wrap, and related non-woven materials. Headquartered in Charlotte, North Carolina, Magnera operates with approximately 8,000 employees globally.

Revenue expanded from $1.08B in FY2021 to $3.20B in FY2025, achieving a 5-year compound annual growth rate of 28.4% from FY2020 through FY2025. Annual sales rose 57.8% in FY2024 and 46.5% in FY2025. Gross margin contracted to 9.0% in FY2025 from 13.3% in FY2021. Magnera has reported net losses in four consecutive years, including -$154.0M in FY2024 and -$159.0M in FY2025. Over the trailing twelve months ended June 30, 2026, revenue stood at $3.28B with quarterly revenue growth of 2.1% year-over-year. Operating margin for the trailing twelve months reached 5.2%, while diluted EPS was -$3.13.

As of June 30, 2026, Magnera held $280.0M in cash and short-term investments against total debt of $1.96B, resulting in net debt of $1.68B. Total assets were $3.83B alongside shareholders' equity of $1.02B, yielding a debt-to-equity ratio of 1.93. The company maintained a current ratio of 2.45. Operating cash flow totaled $103.0M in FY2025 with capital expenditures of $67.0M, generating $36.0M in free cash flow.

Magnera carries an enterprise value of $2.07B and a market capitalization of $396.1M. The stock trades at a forward price-to-earnings multiple of 13.7x, compared to 14.3x for the median of its US-listed Consumer Defensive peers. Its price-to-sales ratio of 0.1x sits below the peer median of 0.7x, while its EV-to-EBITDA ratio of 82.7x is well above the peer median of 11.7x. Over the past year, the stock returned 18.8%, slightly outpacing the 16.8% gain for the S&P 500 (SPY), though its 5-year return stands at -94.5% compared to 83.0% for the index.

Wall Street coverage includes 2 Hold ratings, with 0 Buy and 0 Sell ratings. The mean price target is $15.50, which sits 40.3% above the October 16, 2026 closing price of $11.05. For the current fiscal year ending September 30, 2026, consensus estimates anticipate EPS of $0.74 on revenue of $3.34B. For the next fiscal year, 2 analysts project EPS of $1.63 and revenue of $3.43B, representing revenue growth of 2.5%. Over the last 4 quarters, Magnera exceeded EPS estimates 1 time, with its next earnings report scheduled for November 4, 2026.

This page is an AI-written research summary of Magnera Corp placeholder (MAGN). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: MAGN income statement, MAGN balance sheet, MAGN key metrics, MAGN analyst forecast, MAGN chart. See the MAGN stock overview for the latest quote and news.